Loading [MathJax]/jax/output/SVG/jax.js

A novel model for intersections of vehicular traffic flow

  • This paper deals with intersections' modeling for vehicular traffic flow governed by the Lighthill & Whitham [24] and Richards [26] model. We present a straightforward reformulation of recent intersections' models, introduced in [19] and [4], using a description in terms of supply and demand functions [22, 6]. This formulation is used to state the new model which takes into account a possible storage capacity of an intersection as seen in roundabouts or highway on-ramps. We discuss the Riemann problem at the junction and present numerical simulations.

    Citation: Michael Herty, J.-P. Lebacque, S. Moutari. A novel model for intersections of vehicular traffic flow[J]. Networks and Heterogeneous Media, 2009, 4(4): 813-826. doi: 10.3934/nhm.2009.4.813

    Related Papers:

    [1] Sarafa A. Iyaniwura, Musa Rabiu, Jummy F. David, Jude D. Kong . Assessing the impact of adherence to Non-pharmaceutical interventions and indirect transmission on the dynamics of COVID-19: a mathematical modelling study. Mathematical Biosciences and Engineering, 2021, 18(6): 8905-8932. doi: 10.3934/mbe.2021439
    [2] Fang Wang, Lianying Cao, Xiaoji Song . Mathematical modeling of mutated COVID-19 transmission with quarantine, isolation and vaccination. Mathematical Biosciences and Engineering, 2022, 19(8): 8035-8056. doi: 10.3934/mbe.2022376
    [3] Stefanie Fuderer, Christina Kuttler, Michael Hoelscher, Ludwig Christian Hinske, Noemi Castelletti . Data suggested hospitalization as critical indicator of the severity of the COVID-19 pandemic, even at its early stages. Mathematical Biosciences and Engineering, 2023, 20(6): 10304-10338. doi: 10.3934/mbe.2023452
    [4] Yujie Sheng, Jing-An Cui, Songbai Guo . The modeling and analysis of the COVID-19 pandemic with vaccination and isolation: a case study of Italy. Mathematical Biosciences and Engineering, 2023, 20(3): 5966-5992. doi: 10.3934/mbe.2023258
    [5] Yuri Amemiya, Tianwen Li, Hiroshi Nishiura . Age-dependent final size equation to anticipate mortality impact of COVID-19 in China. Mathematical Biosciences and Engineering, 2023, 20(6): 11353-11366. doi: 10.3934/mbe.2023503
    [6] Pannathon Kreabkhontho, Watchara Teparos, Thitiya Theparod . Potential for eliminating COVID-19 in Thailand through third-dose vaccination: A modeling approach. Mathematical Biosciences and Engineering, 2024, 21(8): 6807-6828. doi: 10.3934/mbe.2024298
    [7] Yuto Omae, Yohei Kakimoto, Makoto Sasaki, Jun Toyotani, Kazuyuki Hara, Yasuhiro Gon, Hirotaka Takahashi . SIRVVD model-based verification of the effect of first and second doses of COVID-19/SARS-CoV-2 vaccination in Japan. Mathematical Biosciences and Engineering, 2022, 19(1): 1026-1040. doi: 10.3934/mbe.2022047
    [8] Xiaojing Wang, Yu Liang, Jiahui Li, Maoxing Liu . Modeling COVID-19 transmission dynamics incorporating media coverage and vaccination. Mathematical Biosciences and Engineering, 2023, 20(6): 10392-10403. doi: 10.3934/mbe.2023456
    [9] Ahmed Alshehri, Saif Ullah . A numerical study of COVID-19 epidemic model with vaccination and diffusion. Mathematical Biosciences and Engineering, 2023, 20(3): 4643-4672. doi: 10.3934/mbe.2023215
    [10] Biplab Dhar, Praveen Kumar Gupta, Mohammad Sajid . Solution of a dynamical memory effect COVID-19 infection system with leaky vaccination efficacy by non-singular kernel fractional derivatives. Mathematical Biosciences and Engineering, 2022, 19(5): 4341-4367. doi: 10.3934/mbe.2022201
  • This paper deals with intersections' modeling for vehicular traffic flow governed by the Lighthill & Whitham [24] and Richards [26] model. We present a straightforward reformulation of recent intersections' models, introduced in [19] and [4], using a description in terms of supply and demand functions [22, 6]. This formulation is used to state the new model which takes into account a possible storage capacity of an intersection as seen in roundabouts or highway on-ramps. We discuss the Riemann problem at the junction and present numerical simulations.


    Some millennia ago, epidemics were mainly of interest to historians. The last 95 years has resulted in a dramatic turn in events. From the outbreak of the Spanish flu in 1918–1919 [1], to herpes and legionnaires disease in the early 70s to the discovery of acquired immunodeficiency syndrome (AIDS) and Ebola, the world has witnessed highly contagious diseases that have threatened human existence [2]. A complete historical account of outbreaks was documented by Brauer [1]. According to Velevan and Meyer [3], coronaviruses were initially identified in 1966 by Tyrell et al. [4]. Recently, according to Guarner [5], the world has witnessed the emergence of three coronaviruses that have led to outbreaks, causing troubling worldwide health and economic concerns. The first two are the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome coronavirus (MERS-CoV) that both have case fatality rates of about 9.5 and 35%, respectively. The most recent disease currently ravaging the world population is COVID-19. Though the virus was recognized in December 2019 [6], the first official case was reported on the 7th of January 2020. Due to several factors, the spread of the virus has been rapid. It has led the leadership of the World Health Organization (WHO) Emergency Committee to declare the infection a pandemic and a global health emergency [3]. A slight solace is that COVID-19 fatality rate is at 23%, unlike the other coronaviruses.

    The use of mathematical models in aiding effective decision making in public health and clinical medicine has been acknowledged by Porgo et al. [7]. Several modelling frameworks are often proposed to understand the spread of diseases within a population and develop short- and long-term control strategies [8]. One of such is the use of mathematical models, which are often deployed to capture the dynamics of the disease at different stages [9]. Several authors such as Kassa et al. [10], Ndairou et al. [11], Zhang et al. [12] among others have come up with several models that fully capture the different transmission modes of the Covid-19 infection and inculcated several intervention strategies. Their results show that mathematical models are imperative in the fight against the spread of the disease.

    Given that COVID-19 was officially reported in January 2020 and months later, several countries are yet to experience the peak of the disease and vaccine has been unavailable, it is imperative to consider the influence of several non-pharmaceutical interventions. Several scientists such as Zhang et al. [12] evaluated interventions like social distancing, school closures, isolation and quarantine. While their studies revealed the positive influence of these measures on reducing the spread, their findings do not represent the situation worldwide. Based on statistics provided by Bargain and Ulugbek [13] and Olopade et al. [14], among others, several countries have more than half the population living below the poverty line. It is also important to note that some of these countries are densely and highly populated.

    In light of the above observation, it is essential to consider various mitigation factors in poverty-ravaged countries where most of the population live below the poverty line, where unemployment is rife, and a high number of people share a small space and limited facilities exist. In such countries, the disparity in wealth means only a small percentage of the population can afford to execute all the mitigation processes comfortably without being a risk to others. Taking South Africa as a case in point, which this study will focus on, 14% of the population lives in an informal settlement, and there is an unemployment rate of 29% with a significant percentage having menial employment [15]. A rigorous study conducted by Garba et al. [16] within the South African context found that if all the control measures implemented by the government were put in place early and for a sustained period, the disease would subsequently die out, which is excellent. The downside, however, is that a particular set of the population, especially the unemployed and the low-income earners, would find it even harder to survive economically.

    The study by Stiegler and Bouchard [15] found that the phased approach used by the government worked, but given that the study was conducted in May 2020 and 6 months later, South Africa went into a second wave means that the strategy needs revisiting. Based on the respondents reported in the study, it is clear that people's attitude to the government response to the COVID-19 situation differs for the middle-class and poor respondents. Furthermore, Arndt et al. [17] conducted a study focusing on the impact of government response on food security. They found that the mitigation approach of distancing directly impacted the wage income, particularly for low-skilled workers, and suggested that the initial lockdown policies had a detrimental impact on the food security of low-income households. These studies highlight the need to construct a model that focuses on measures that can help curb the spread of the virus while allowing unemployed and low-income earners to go about their daily business. Therefore, there is a need to apply a two-pronged approach to curb the spread of COVID-19. Therein lies the objective of this study.

    We aim to construct a model that caters for non-pharmaceutical measures and also takes into consideration the impact of vaccination in anticipation of the arrival of vaccines and the significant number of people against vaccination (see Megget [18] and De Roo et al. [19]). We also investigate the potential impact of vaccine efficacy on the reproduction number. We carry out the stability analysis of the disease-free equilibrium point and sensitivity of the effective reproduction number to the model's parameters. We investigate the impact of combining both pharmaceutical and non-pharmaceutical measures in curbing the spread of the infection.

    In this section, we propose a mathematical model of the dynamics of COVID-19 and mitigation measures. This model assumes that the total population N(t) is divided into seven classes; namely, the susceptible class S(t), the vaccinated class Sv(t), the exposed class E(t), the quarantined class Q(t), the infected class I(t), the hospitalized class H(t) and recovered class R(t). We assume that the susceptible class is vaccinated at a rate ϕ and the vaccine has an efficacy rate (1σ), where σ=0 indicates a failed vaccination and σ=1 depicts a perfectly effective vaccination. The vaccine is assumed to dwindle at a constant rate ρ, such that individuals that are vaccinated have immunity for a period of 1/ρ time unit. It is assumed that individuals who have failed vaccination may become exposed and inadvertently become infected at a lower infection rate βζ(1σ)ISv/N than individuals from the susceptible population who are unvaccinated, who become infected at a rate βζIS/N, where β is the probability of transmission and ζ is the effective contact rate. Individuals exposed to the virus are kept in quarantine at a rate ν and those who show clinical symptoms are hospitalized and treated for COVID-19 symptoms at a constant rate b, with a recovery rate τ. However, quarantined individuals who show no symptoms during the fourteen-day incubation period rejoin the susceptible compartment at a rate ω, while individuals who show clinical symptoms progress to the infected class at p. We considered natural death and assumed that the mortality rate is μ, while COVID-19 related mortality rate is δ.

    The system of differential equations describing the model is derived using the assumptions mentioned above and the flow diagram in Figure 1, and are expressed as follow:

    ˙S=Π(ϕ+μ)S+ρSv+ωQ+ηRβζISN (2.1a)
    ˙Sv=ϕSρSvβζ(1σ)ISvNμSv (2.1b)
    ˙E=βζSIN+βζ(1σ)ISvN(ν+α+μ)E (2.1c)
    ˙Q=νE(p+ω+μ)Q (2.1d)
    ˙I=αE+pQ(b+δ+μ)I (2.1e)
    ˙H=bI(τ+δ+μ)H (2.1f)
    ˙R=τH(η+μ)R, (2.1g)

    with the initial conditions

    S(0)0,Sv(0)0,E(0)0,Q(0)0,I(0)0,H(0)0,R(0)0. (2.2)
    Figure 1.  Transition diagram of the COVID-19 dynamics.

    We use the daily number of COVID-19 infections reported in South Africa to estimate some of the parameter values in the system of Eq (2.1). Figure 2 shows the trend of the daily number of new infections reported [20]. We consider two stages, the first stage represents the onset of the disease and the phase when mitigation strategies were first implemented. The second stage represents the stage when the implementation of mitigation strategies was at its peak. We use the genetic algorithm optimization technique to estimate the parameters. For both stages, we consider Eq (2.1) without the vaccinated component or the vaccination parameters, such that the model reduces to

    ˙S=ΠμS+ωQ+ηRβζSIN,˙E=βζSIN(ν+α+μ)E,˙Q=νE(p+ω+μ)Q,˙I=αE+pQ(b+δ+μ)I,˙H=bI(τ+δ+μ)H,˙R=τH(η+μ)R. (2.3)
    Figure 2.  Trend of daily number of new infections in South Africa from 05/03/2020 to 24/10/2020.

    For the first stage, we consider the COVID-19 data from 05/03/2020 until 17/07/2020, and the second stage from 17/07/2020 to 24/10/2020. To estimate the parameters for the first stage, given that there were very few known cases, we assumed that the initial number of exposed individuals is 20, that is E(0)=20. The infected class initial value I(0) is 5, the number of cases reported on the 5th of March 2020. The recruitment rate Π is evaluated using μN, where N=58.56×106 is South Africa total population and μ=1/(63.86×365) is the natural mortality rate [21]. The initial values of the Q and R components are assumed to be zero, and S(0)=NE(0)I(0). For the second stage, the components initial values are taken to be the terminal values of the first stage. Figure 3 shows the curves of the daily number of infections simulated by model (2.3) and the reported data. In Table 1, we present the estimated parameter values in both stages. Because the implementation of mitigation strategies was at its peak, contact rate and transmission probability in the second stage are lower than the corresponding values in the first stage.

    Figure 3.  Comparison of the daily numbers of infection simulated in the model and the numbers reported for the first and second stages.
    Table 1.  Description of parameters and range of values used in simulation.
    Parameter Description 1st stage 2nd stage
    β Probability of transmission during contact 0.0122 0.0059
    ζ Contact rate between an infected and susceptible individual 8.51 5.6242
    α Progression rate from exposed to infected 0.2254 0.1056
    ν Rate of quarantine of exposed individuals 0.1988 0.0024
    p Rate of progression from quarantine to infected 0.3835 0.1132
    ω Rate at which quarantined individuals are confirmed noninfectious 0.1997 0.9383
    η Rate of progression from recovery back to susceptible 0.5646 0.2321
    b Rate of hospitalization of infected individuals 0.0191 0.0577
    τ Average recovery rate 0.0482 0.0590
    δ Disease–induced death rate 0.0053 0.0293

     | Show Table
    DownLoad: CSV

    This section presents some theoretical results wherein we obtain the disease-free equilibrium point and analyze its local stability. We prove that the model Eq (2.1) is well-posed, bounded, and its solutions are positive, and then proceed to obtain the effective reproduction number at the disease-free equilibrium point.

    Theorem 1. Assume that {S(0)0,Sv(0)0,E(0)0,Q(0)0,I(0)0,H(0)0,R(0)0} are the initial values of the solutions of equations (2.1). The solution set

    {S(t),Sv(t),E(t),Q(t),I(t),H(t),R(t)}

    are all non-negative for all t0, provided all parameters are positive.

    Proof. By continuous dependence of the solutions on initial conditions, we only need to show the solution set is positive, given that the initial conditions are positive. From Eq (2.1d), and by using the method of integrating factor, we have

    Q(t)=e(p+ω+μ)t[Q(0)+νt0e(p+ω+μ)rE(r)dr]0. (3.1)

    Similarly, from Eq (2.1f)

    H(t)=e(τ+δ+μ)t[H(0)+bt0e(τ+δ+μ)rI(r)dr ]0. (3.2)

    Similar approach can be used for the other equations, and this guarantees the positivity of the solutions. Therefore, the system is positively invariant in R7+.

    Theorem 2. The model (2.1) is well-posed, and the solution is bounded and invariant in the region

    Λ={(S,Sv,E,Q,I,H,R)R7+:N(t)Πμ}. (3.3)

    Proof: We know that

    ˙N=˙S+˙Sv+˙E+˙Q+˙I+˙H+˙R (3.4)
    =ΠμNδ(I+H). (3.5)

    Assume that there is no disease-induced death, then

    ˙N=ΠμN. (3.6)

    Therefore,

    N(t)=Πμ(1eμt)+N(0)eμtΠμ, (3.7)

    where N(0) is the initial value of the total population. Equation (3.7) implies that the model is well-posed, and solutions are bounded in Λ.

    Assume that there are no infectious individuals at the disease-free state, then E0=I0=0. Consequently, Q0=H0=R0=0, and

    S0=(ρ+μ)Πμ(ϕ+ρ+μ),S0v=Πϕμ(ϕ+ρ+μ). (3.8)

    Therefore, the disease-free equilibrium point is obtained as

    ξ0=((ρ+μ)Πμ(ϕ+ρ+μ),Πϕμ(ϕ+ρ+μ),0,0,0,0,0). (3.9)

    For the study of the stability properties of the model (2.1), we will use the effective reproduction number, which is the average number of secondary cases produced by one infected individual during its entire infectious period in an otherwise uninfected population [22]. From a mathematical viewpoint, the value of the effective reproduction number associated with the epidemiological model Eq (2.1a) to (2.1g) can be computed as the spectral radius of the next–generation matrix (see Heesterbeek and Dietz [22] and Van den Driessche and Watmough [23] for more details). We do this by decomposing the infectious compartments of the model into FV, and finding the next-generation matrix FV1 at the disease-free equilibrium point. F and V are respectively the Jacobian of the matrices F and V defined as:

    F=[βζSIN+βζ(1σ)SvIN000],V=[(ν+α+μ)EνE+(p+ω+μ)QαEpQ+(b+δ+μ)IbI+(τ+δ+μ)H]. (3.10)

    Therefore,

    F=[00βζS0N+βζ(1σ)S0vN0000000000000],V=[ν+α+μ000νp+ω+μ00αpb+δ+μ000bτ+δ+μ], (3.11)

    and the next generation matrix (NGM) is obtained as

    NGM=βζ(S0+(1σ)S0v)N[α(p+ω+μ)+pν(ν+α+μ)(p+ω+μ)(b+δ+μ)p(p+ω+μ)(b+δ+μ)1b+δ+μ0000000000000]. (3.12)

    The effective reproduction number is the spectral radius of the next generation matrix. In this case, the spectral radius of NGM is the matrix's only non-zero eigenvalues. Thus, the effective reproduction number of the epidemiological model (2.1) is obtained as follow:

    Rvac=βζ(S0+(1σ)S0v)Nα(p+ω+μ)+pν(ν+α+μ)(p+ω+μ)(b+δ+μ)=βζ(ρ+μ+(1σ)ϕ)(ϕ+ρ+μ)α(p+ω+μ)+pν(ν+α+μ)(p+ω+μ)(b+δ+μ). (3.13)

    The linear relationship between the reproduction number and the probability of transmission is quite apparent. We can decompose the effective reproduction number into two parts such that

    Rvac=Ri+Rq, (3.14)

    where

    Ri=βζ(ρ+μ+(1σ)ϕ)α(ϕ+ρ+μ)(ν+α+μ)(b+δ+μ),Rq=βζ(ρ+μ+(1σ)ϕ)pν(ϕ+ρ+μ)(ν+α+μ)(p+ω+μ)(b+δ+μ).} (3.15)

    Ri represents the contribution of individuals who are exposed and subsequently become infected to the spread of the infection. In contrast, Rq represents the contribution of individuals who progressed to the infected compartment from quarantine to the spread of the disease. We can define the effective reproduction number in terms of the basic reproduction number R0 without vaccination as

    Rvac=R0[1σϕ(ϕ+ρ+μ)], (3.16)

    where

    R0=Ri0+Rq0=βζα(ν+α+μ)(b+δ+μ)+βζpν(ν+α+μ)(p+ω+μ)(b+δ+μ). (3.17)

    Given the positivity of the parameters, 1σϕ(ϕ+ρ+μ)<1, and it corresponds to the vaccine administration rate. If R0 is less than unity, we can easily see that Rvac<1. However, if R0 is greater than one, it is imperative to ask if the administration of a vaccine would make Rvac<1. In that case, the vaccination rate must satisfy the following inequality

    ϕ>(R01)(ρ+μ)R0(σ1)+1, (3.18)

    for which R0(σ1)+1>0, which implies that the vaccine efficacy rate σ must be greater than 11/R0. This simply means that; given the critical vaccination rate ϕc defined as

    ϕc=(R01)(ρ+μ)R0(σ1)+1. (3.19)

    There is a region in the domain of the parameters where we can make the effective reproduction number less than one. We illustrate this using the parameter values estimated from the model fitting process. We calculate the basic reproduction number from the two stages and present them in Table 2. The values obtained in Table 2 show that strict implementation of the mitigation strategies significantly reduces the basic reproduction number. In the shaded region in Figure 4, Rvac<1. By assuming that vaccinated individuals are immune for 365 days, we can see that with about 75% vaccine efficacy and a good vaccination rate, it is possible to make the effective reproduction number less than unity. This implies that if a reoccurrence of stage 1 happens in South Africa, utilizing non-pharmaceutical measures, such as quarantine and reducing contact rate, combined with a vaccine that has 75% efficacy, the rate of secondary infection can be kept to the minimum.

    Table 2.  Estimated values of the basic reproduction number.
    Ri0 Rq0 R0
    1st Stage 2.2567 1.3087 3.5655
    2nd Stage 0.3743 9.2179×104 0.3743

     | Show Table
    DownLoad: CSV
    Figure 4.  Feasibility region of the vaccination and vaccine efficacy rates. In the shaded region, Rvac<1.

    Theorem 3. The disease-free equilibrium point is asymptotically stable whenever Rvac<1 and unstable otherwise.

    Proof. Evaluating the linearized Jacobian at the disease-free equilibrium point, we have

    J(ζ0)=F(ζ0)V(ζ0)=[k10A0νk200αpk3000bk4], (3.20)

    where

    A=βζ(ρ+μ+(1σ)ϕ)(ϕ+ρ+μ),k1=ν+α+μ,k2=p+ω+μ,k3=b+δ+μ,k4=τ+δ+μ} (3.21)

    are non-negative. To show that the disease–free equilibrium point is locally asymptotically stable, we must show that the eigenvalues of J(ζ0) have negative real part if Rvac<1. The characteristics polynomial of the Jacobian J(ζ0) is given as

    λ0κ4+λ1κ3+λ2κ3+λ3κ+λ4=0, (3.22)

    where

    λ0=1,λ1=k1+k2+k3+k4,λ2=k1k2+k2k3+k1k4+k2k4+k3k4+k1k3(1Rvac+Ri),λ3=k1k2k4+k2k3k4v+k1k2k3(1Rvac)+k1k3k4(1Rvac+Rq),λ4=k1k2k3k4(1Rvac).} (3.23)

    To show that the disease-free equilibrium point is locally asymptotically stable, it suffices to prove, by the Routh–Hurwitz stability criterion for fourth–order polynomials, that λ0>0,λ1>0,λ4>0,λ1λ2λ0λ3>0 and (λ1λ2λ0λ3)λ3λ21λ4>0. These conditions are satisfied whenever Rvac<1 as shown in Appendix A.1. Therefore, the disease-free equilibrium point is locally asymptotically stable.

    This section uses the application of the Lyapunov function to establish the global stability of the disease-free equilibrium.

    Definition 1. Given the dynamical system, ˙X=G(X), with equilibrium point, X, such that G:RnRn. We define a continuous scalar function L:RnRn. L is said to be positive definite if the conditions

    L(X)=0,L(X)>0XX,

    are satisfied. If L(X) as X, then L(X) is radially unbounded [24].

    Theorem 4 (Lyapunov's Stability Theorem).The equilibrium point, X, is globally stable if L(X) is a Lyapunov function such that ˙L(X)<0 for all XX.

    An extension of the Lyapunov stability theorem is the LaSalle invariance principle which partially states that, given a dynamical system ˙X=G(X) with equilibrium, X, such that G(X)=0, X is globally stable if there is a continuously differentiable Lyapunov function which satisfies

    ˙L(X)0{t,X}Rn+.

    This allows us to define an invariant set {XRn+st˙L=0}, such that the only maximal compact set in the invariant set is the equilibrium point, X. See Martcheva [24] for the proof of this theorem.

    Theorem 5. The disease free equilibrium point, ξ0, is globally asymptotically stable whenever Rvac<1.

    Proof. To prove this theorem, we define a Lyapunov function

    L=E+ι1Q+ι2I+ι3H, (3.24)

    where the constants, ι1,ι2 and ι3, are to be determined. Differentiating Eq (3.24) with respect to time and substituting ˙E,˙Q,˙I,˙H from Eq (2.1), we have

    ˙L=(βζSN+βζ(1σ)SvNι2k3+ι3b)I+(ι1ν+ι2αk1)E+(ι2pι1k2)Qι3k4H. (3.25)

    If the coefficients of E,Q and H are equated to zero, we obtain the following positive values for ι1,ι2 and ι3

    ι1=pk1pν+αk2,ι2=k1k2pν+αk2,ι3=0.

    Therefore, we can define a Lyapunov, L, for the disease-free equilibrium point, ξ0, as follow

    L=E+(pk1pν+αk2)Q+(k1k2pν+αk2)I. (3.26)

    Differentiating Eq (3.26) with respect to t and substituting ˙E,˙Q,˙I from Eq (2.1) gives

    ˙L(ξ0)=(βζ(ρ+μ)(ϕ+ρ+μ)+βζ(1σ)ϕ(ϕ+ρ+μ)k1k2k3pν+αk2)I=k1k2k3pν+αk2(Apν+αk2k1k2k31)I=k1k2k3pν+αk2(Rvac1)I<0, (3.27)

    whenever Rvac<1.

    Furthermore, ˙L(ξ0)=0(E=Q=I=H=0). Therefore, the singleton set {ξ0} is the only compact set in the invariant set {(S,Sv,E,Q,I,H,R)R7+st˙L=0}, and thus by the LaSalle invariance principle, the disease-free equilibrium, ξ0, is globally asymptotically stable if Rvac<1.

    This study deals with a model for the dynamics of COVID-19 with vaccination. Numerical simulations were carried out for the system of equations (2.1) with the range of parameter values detailed in Table 1. The parameter values were sampled using the Latin Hypercube Sampling, and these samples were used to carry out a series of numerical simulations for the model. 2500 values were sampled for each parameter. A partial rank correlation analysis was carried out between the sampled values of the parameters and the values of important response variables, such as the effective reproduction number, the cumulative vaccinated population, the cumulative infected population and the cumulative hospitalized population. In Table 3, the partial rank correlation coefficient (PRCC) for each response variable for the parameters are presented. The PRCC values show the important parameters in the dynamics of the administration of control and preventive measures on the infection rate of COVID-19. We note here that the parameters with large PRCC values, that is >0.5 or <0.5 and p-value 0.05 are the most significant parameters. The closer the PRCC value is to positive or negative unity, the higher their influence on the measured variable. The sign of the PRCC value indicates the qualitative relationship between the parameter and the response function. A positive sign means a direct relationship between the parameter and measured variable, while a negative sign indicates otherwise.

    Table 3.  Partial rank correlation coefficients and p-values for some model parameters using the effective reproduction number, the total number of vaccinated, infected and hospitalized individuals as response functions.
    Parameter Rvac Sv I H
    PRCC p–value PRCC p–value PRCC p–value PRCC p–value
    ϕ -0.1042 1.7873 × 10–7 +0.9707 0 -0.8662 0 -0.7929 0
    ρ +0.0498 0.0128 -0.5982 1.6397 × 10–242 -0.0030 0.8804 -0.0012 0.9521
    σ -0.7947 0 -0.1075 7.1819 ×10–8 +0.7479 0 +0.5923 1.2269 × 10–236
    β +0.8235 0 -0.5412 3.0486 × 10–190 +0.2514 2.3928 × 10–37 +0.2749 1.2788 × 10–44
    ζ +0.6997 0 -0.4745 1.5210 ×10–140 +0.2418 1.3614 ×10–34 +0.2520 1.6151 ×10–37
    α +0.1531 1.3854 ×10–14 -0.1959 4.8709 ×10–23 +0.2082 6.9136 ×10–26 +0.1597 9.4106 ×10–16
    ν -0.1892 1.4066 ×10–21 -0.0128 0.5211 -0.0108 0.5906 -0.0109 0.5871
    p +0.1779 3.0789 ×10–19 -0.0466 0.0197 +0.0717 0.0003 +0.0399 0.0463
    ω -0.1368 6.5155 ×10–12 +0.0095 0.6365 -0.0542 0.0067 -0.0444 0.0263
    η +0.0150 0.4532 -0.0191 0.3407 -0.0092 0.6444
    b -0.4419 5.1498 ×10–120 +0.0878 1.1065 ×10–5 -0.1865 5.3180 ×10–21 +0.4852 8.2726 ×10–148
    τ +0.0148 0.4589 +0.0229 0.2517 -0.6461 1.7811 ×10–295
    δ -0.4767 4.9407 ×10–142 -0.0652 0.0011 -0.1944 1.0256 ×10–22 -0.2167 5.884 ×–28

     | Show Table
    DownLoad: CSV

    In Table 4, we ordered the PRCC values of each measured function for each parameter in descending order of ranking. For the effective reproductive number, it can be seen that the top three ranked parameters are the probability of transmission, vaccine efficacy rate, and effective contact rate. In contrast, the bottom-ranked parameter is the vaccination waning rate. The two highest-ranked parameters for the cumulative vaccinated population are the vaccination rate and the vaccine waning rate. In contrast, the lowest-ranked parameter is the rate at which quarantined individuals are confirmed non-infectious, which is insignificant in the dynamics of the vaccinated population. Amongst the topmost ranked parameters in the infected compartment is the vaccination rate and effective contact rate. This show how significant pharmaceutical measures such as vaccination and non-pharmaceutical measures like reducing contact between infected and susceptible individuals can affect the dynamics of the infected individuals in South Africa and inadvertently affect the dynamics of the hospitalized compartment. The results in Table 4 show that the degree of efficacy of a vaccine would be significant in the dynamics of the rate of infection of COVID-19, as this parameter is highly ranked and statistically significant for each response function. For instance, the vaccine efficacy rate is second in significance to the transmission probability for the effective reproduction number. This indicates that the efficacy of the anticipated vaccine would be as significant or, to some extent, more important than the rate of administration of the vaccine.

    Table 4.  Ranking of the parameters from the most to least significant parameter using the partial rank correlation coefficients as metric.
    Rvac Sv I H
    Ranking Significant? Ranking Significant? Ranking Significant? Ranking Significant?
    β TRUE ϕ TRUE ϕ TRUE ϕ TRUE
    σ TRUE ρ TRUE σ TRUE τ TRUE
    ζ TRUE β TRUE β TRUE σ TRUE
    δ TRUE ζ TRUE ζ TRUE b TRUE
    b TRUE α TRUE α TRUE β TRUE
    ν TRUE σ TRUE δ TRUE ζ TRUE
    p TRUE b TRUE b TRUE δ TRUE
    α TRUE δ TRUE p TRUE α TRUE
    ω TRUE p TRUE ω TRUE ω TRUE
    ϕ TRUE η FALSE τ FALSE p TRUE
    ρ TRUE τ FALSE η FALSE ν FALSE
    ν FALSE ν FALSE η FALSE
    ω FALSE ρ FALSE ρ FALSE

     | Show Table
    DownLoad: CSV

    We use sensitivity analysis to determine the relative importance of each parameter in the effective reproduction number. We define the sensitivity index for any parameter, say x, as

    ΓxRvac=RvacxxRvac. (4.1)

    Therefore, the sensitivity indexes of the parameters with respect to effective reproduction number are given as follow:

    ΓβRvac=1,ΓρRvac=σϕρ(σϕ+μ+ϕ+ρ)(ϕ+ρ+μ),ΓσRvac=ϕσ(ϕσ+μ+ϕ+ρ),ΓϕRvac=(μ+ρ)σϕ(ϕσ+μ+ϕ+ρ)(ϕ+ρ+μ),ΓωRvac=νpω(μα+νp+pα+αω)(p+ω+μ),ΓpRvac=(μ+ω)νp(μα+νp+pα+αω)(p+ω+μ),ΓbRvac=bb+δ+μ,ΓδRvac=δb+δ+μ,ΓνRvac=ν(νpνααω)(μα+νp+pα+αω)(ν+α+μ),ΓαRvac=(μ2+μν+μp+μω+νω)α(μα+νp+pα+αω)(ν+α+μ),ΓζRvac=1.

    A positive sensitivity index, on the one hand, of the model output Rvac for any parameter, say x, implies that a percentage increase/decrease in x will result in a Γ% increase/decrease in Rvac. On the other hand, a negative sensitivity index implies that a percentage increase/decrease in parameter x will lead to a Γ% decrease/increase in x. Rvac grows at the same proportion with the transmission probability and effective contact rate. In contrast, control parameters such as hospitalization rate, quarantine rate, vaccination rate and vaccination efficacy rate are inversely proportional to the reproduction number.

    The sensitivity indexes in Table 5 are arranged in descending order of magnitude, placing the most significant parameter at the top. In this case, we used the parameter values obtained from fitting the model and assumed that a vaccine with 75% efficacy, giving immunity for 365 days, is administered at a 50% ratio. The table shows that the vaccine's efficacy, σ, is the most significant parameter. The obtained sensitivity index of Rvac for σ indicates that a 1% increase in the vaccine effectiveness will lead to an approximately 3% decrease in the number of secondary infections. Other control measures, such as limiting the contact rate between the susceptible and infected population, maximizing the treatment of infected individuals, and isolating exposed individuals, are also pivotal in minimizing the number of secondary infections. We already know that if there is no vaccination and using the values in Table 5, we obtain a basic reproduction number of 3.5655. However, including vaccination and vaccine efficacy significantly reduces the reproduction number to 0.9062. Figure 5 presents the effective reproduction number as a function of transmission probability (β) and contact rate (ζ). The figure shows the significance of the transmission probability in bringing the effective reproduction number below unity. It shows that a drastic reduction in the transmission probability to about 0.05, which can be facilitated by personal hygiene, sanitation and wearing of a mask, can significantly reduce the infection rate as seen in Figure 5b. In Figure 6a, the reproduction number is plotted as a function of vaccination rate and vaccine efficacy. Again, we can see in Figure 6a that a vaccine with about 75% efficacy can reduce the reproduction number to less than 1, while Figure 6b shows the importance of combining both pharmaceutical and non-pharmaceutical approaches in reducing the spread of the virus.

    Table 5.  Sensitivity index of parameters that are related to the effective reproduction number.
    Parameter Nominal value Source Sensitivity index
    σ 0.75 Assumed -2.9347
    β 0.0122 Fitted +1
    ζ 8.51 Fitted +1
    b 0.0191 Fitted -0.7814
    δ 0.0053 Fitted -0.2168
    p 0.3835 Fitted +0.1257
    ω 0.1997 Fitted -0.1257
    α 0.2254 Fitted +0.1016
    ν 0.1988 Fitted -0.0306
    ϕ 0.5 Assumed -0.0162
    ρ 1/365 Assumed +0.0160
    μ 1/(63.86×365) Ref. [21]

     | Show Table
    DownLoad: CSV
    Figure 5.  Contour plot of Rvac as a function of effective contact rate (ζ) and transmission probability (β).
    Figure 6.  Plots of Rvac as a function of vaccination rate (ϕ) and vaccine efficacy (σ), and as a function of vaccination rate (ϕ) and transmission probability (β).

    In this study, a model describing the transmission of COVID-19 with the implementation of pharmaceutical and non-pharmaceutical mitigation measures was proposed. To contextualize the South African situation, emphasis has been placed on more adaptable measures like personal hygiene, sanitation, wearing of mask, social distancing, and vaccination. The disease-free equilibrium point analysis was obtained, and the local stability analysis of the point was performed. We obtained the reproduction number at the disease-free equilibrium point and further analyzed the sensitivity of the reproduction number to some of the parameters considered in the model.

    The results obtained indicate that, in the South African context, a vaccine with at least 75% efficacy coupled with other non-pharmaceutical measures that minimize the probability of infection such as personal hygiene and protective gear can significantly decrease the rate of secondary infection. The importance of quarantine and isolation of exposed individuals has been established in studies. Still, we have also established the importance of adhering to measures that mitigate the risk of infection even if they have contact with an exposed or infected individual.

    As we await the production and administration of the vaccine for the general public, the results of this study indicate that control measures such as personal hygiene, use of protective gear, limiting physical and social interactions should be adhered to to reduce the transmission of the virus.

    The authors would like to acknowledge the support of the School of Computer Science and Applied Mathematics, University of Witwaterstrand.

    The authors declare that there are no conflicts of interest.

    In this section, we show the positivity of the sequence of determinants of the principal sub-matrices of the Hurwitz matrix of the characteristics polynomial (3.22). That is, given the polynomial (3.22)

    λ0κ4+λ1κ3+λ2κ3+λ3κ+λ4=0,

    where

    λ0=1,λ1=k1+k2+k3+k4,λ2=k1k2+k2k3+k1k4+k2k4+k3k4+k1k3(1Rvac+Ri),λ3=k1k2k4+k2k3k4v+k1k2k3(1Rvac)+k1k3k4(1Rvac+Rq),λ4=k1k2k3k4(1Rvac),

    we want to show that λ0,λ1,λ4,λ1λ2λ0λ3,(λ1λ2λ0λ3)λ3λ21λ4 are all non-negative whenever Rvac is less than unity. λ0 is obviously positive. Note that the parameters k1,k2,k3 and k4 Equation (3.21) are positive. Since this is the case, λ1 and λ4 are non-negative whenever Rvac<1. It remains to show that λ1λ2λ0λ3>0 and (λ1λ2λ0λ3)λ3λ21λ4>0. If we can show that (λ1λ2λ0λ3)λ3λ21λ4 is positive whenever Rvac<1, then λ1λ2λ0λ3>0 whenever Rvac<1. After some algebraic calculations, (λ1λ2λ0λ3)λ3λ21λ4 was obtained as

    (λ1λ2λ0λ3)λ3λ21λ4=Φ1+Φ2+Φ3RiRq+Φ4R2i+Φ5Ri+Φ6R2q+Φ7Rq+Φ8Rq(1Rvac), (A.1)

    where

    Φ1=3k21k22k3k4+3k21k2k3k24+2k1k32k3k4+3k1k22k23k4+4k1k22k3k24+2k1k2k3k34+3k1k2k23k24Φ2=k31k22k4+k31k2k24+k21k33k4+2k21k22k24+k21k2k34+k1k32k24+k1k22k34+k32k23k4+k32k3k24+k22k33k4+2k22k23k24+k22k3k34+k2k33k24+k2k23k34Φ3=3k31k2k23+5k31k22k4+k21k22k23+3k21k2k33+3k21k2k23k4+5k21k33k4+3k21k23k24Φ4=2k31k2k23+2k31k23k4+k21k22k23+2k21k2k33+2k21k33k4+2k21k2k23k4+k21k23k24Φ5=k31k22k3+3k31k2k3k4+k31k3k24+k21k32k3+2k21k22k23+2k21k22k3k4+6k21k2k23k4+2k21k2k3k24+2k21k23k24+k21k3k34+k1k32k23+k1k22k33+2k1k22k23k4+3k1k2k33k4+2k1k2k23k24+k1k33k24+k1k23k34Φ6=k31k2k23+2k31k23k4+k21k2k33+2k21k33k4Φ7=k31k22k3+3k31k2k3k4+2k31k3k24+k21k32k3+2k21k22k23+2k21k22k3k4+5k21k2k23k4+2k21k2k3k24+2k21k23k24+2k21k3k34+k1k32k23+k1k22k33+2k1k22k23k4+k1k22k3k24+3k1k2k33k4+2k1k2k23k24+k1k2k3k34+2k1k33k24+2k1k23k34Φ6=k21k2k23k4+2k21k23k24.} (A.2)

    From Equation (3.15), Ri and Rq are non-negative, and given the positivity of k1,k2,k3,k4, we can conclude that (λ1λ2λ0λ3)λ3λ21λ4>0 whenever Rvac<1.

    We now show the positivity of λ1λ2λ0λ3 whenever Rvac<1. Since (λ1λ2λ0λ3)λ3λ21λ4>0 whenever Rvac<1, we have

    (λ1λ2λ0λ3)λ3λ21λ4>0λ1λ2λ0λ3>λ21λ4λ3. (A.3)

    It is obvious that λ21λ4λ3>0 whenever Rvac<1. Therefore, λ1λ2λ0λ3 is positive whenever Rvac<1. However, for completeness, λ1λ2λ0λ3 was obtained as

    λ1λ2λ0λ3=2k1k2(k3+k4)+k3k4(k1+2k2)+(k21+k23)(k2+k4)+k22(k1+k3+k4)+k24(k1+k2+k3)+(k21k3+k1k23+k1k2k3+2k1k3k4)Ri+(k21k3+k1k23+k1k3k4)(1Rvac)>0,

    whenever Rvac<1.

  • This article has been cited by:

    1. Ayokunle Akinlabi, Ayodele J. Oyejide, Ebenezar O. Atoyebi, Adetokunbo Awonusi, Eti Herbert, Gbeminiyi Oyedele, Moses Abolade, Desk Review on COVID-19 Pandemic in Sub-Sahara Africa: The Challenges and Proffered Solutions, 2022, 3, 2709-2607, 250, 10.51867/ajernet3.1.19
    2. Sylvia K. Ofori, Emmanuelle A. Dankwa, Eve Hiyori Estrada, Xinyi Hua, Teresia N. Kimani, Carrie G. Wade, Caroline O. Buckee, Megan B. Murray, Bethany L. Hedt‐Gauthier, COVID‐19 vaccination strategies in Africa: A scoping review of the use of mathematical models to inform policy, 2024, 29, 1360-2276, 466, 10.1111/tmi.13994
    3. Maria Vittoria Corazza, Ana Pejdo, 2024, 9780443132957, 109, 10.1016/B978-0-443-13295-7.00002-2
    4. Oscar Espinosa, Laura Mora, Cristian Sanabria, Antonio Ramos, Duván Rincón, Valeria Bejarano, Jhonathan Rodríguez, Nicolás Barrera, Carlos Álvarez-Moreno, Jorge Cortés, Carlos Saavedra, Adriana Robayo, Oscar H. Franco, Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review, 2024, 13, 2046-4053, 10.1186/s13643-023-02411-1
  • Reader Comments
  • © 2009 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3913) PDF downloads(297) Cited by(30)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog